Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | February 5, 2024 |
| Target | Elanco Animal Health - Aqua Business |
| Sector | Life Science |
| Buyer(s) | Merck Animal Health |
| Sellers(s) | Elanco |
| Deal Type | Divestiture |
| Deal Value | 1.3B USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1921 |
| Sector | Life Science |
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck. MSD provides veterinary pharmaceuticals, vaccines and health management solutions and services.
| Deal Context for Buyer | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Life Science | 2 of 2 |
| Type: Divestiture | 1 of 1 |
| State: Indiana | 1 of 1 |
| Country: United States | 3 of 3 |
| Year: 2024 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-09-22 |
Vence
San Diego, California, United States Vence provides enhanced technology for producers and ranchers to track, monitor, and manage the movement of cattle through a high-tech platform of virtual fencing solutions. Using a computer or smartphone, customers have the capability to manage cattle movement and facilitate rotational grazing. Vence’s virtual fencing technology can reduce the need for fencing to subdivide pastures and allows producers and ranchers to manage their cattle and grass inventory, while reducing costs of labor and fencing materials. Vence is based in San Diego, California. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1954 |
| Sector | Life Science |
| Employees | 9,000 |
| Revenue | 4.4B USD (2024) |
Elanco develops and markets products and services to improve animal health and protein production in more than 75 countries. Elanco was incorporated in 1954 and is based in Greenfield, Indiana.
| Deal Context for Seller | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 3 of 3 |
| State: Indiana | 3 of 3 |
| Country: United States | 3 of 3 |
| Year: 2024 | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-16 |
Kindred Biosciences
Burlingame, California, United States Kindred Biosciences is a biopharmaceutical company developing biologics focused to develop therapeutics based on these validated targets for dogs and cats. Kindred Biosciences was founded in 2012 and is based in Burlingame, California. |
Buy | $440M |
